A randomised controlled trial assessing the effect of adding clarithromycin to Rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India

Leprosy Review

Volumn 82, Issue 1, 2011, Pages 46-54

  Girdhar, Anita ^a   Kumar, Anil ^a   Girdhar, Bhawneswar Kumar ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MINOCYCLINE; OFLOXACIN; PLACEBO; RIFAMPICIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL EXAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INDIA; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAUCIBACILLARY LEPROSY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; FEMALE; HUMANS; INDIA; LEPROSY, PAUCIBACILLARY; MALE; MIDDLE AGED; MINOCYCLINE; OFLOXACIN; RECURRENCE; RIFAMPIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79957467726     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. WHO. Progress towards elimination of leprosy as public health problem. WHO Weekly Epidemiological Records, 1996; 71: 149-156.
2. Ekambram V, Sithambram M. Self healing in non-lepromatous leprosy in the area of ELEP Leprosy Control Project, Dharampuri (Tamilnadu). Indian J Lepr, 1977; 49: 387-392.
3. Single Lesion Multicentric Trial Group. Efficacy of single dose multidrug therapy for the treatment of single lesion paucibacillary leprosy. Indian J Lepr, 1997; 69: 121-129.
4. Revenkar CR, Pai VV, Antony Samy MS, Ganapati R. Single-dose treatment for PB leprosy; Field implications. (Letter). Int J Lepr, 1999; 67: 312-313.
5. Ganapati R, Revenkar CR, Pai VV, Kingslley S. Single-dose treatment for PB leprosy; feasibility of long term follow upup. (Letter). Int J Lepr, 1999; 67: 308-309.
6. Ji B, Perani EG, Grosset JH. Effectiveness of clarithromycin and minocycline alone and in combination against experimental M. leprae infection in mice. Antimicrob Agents Chemother, 1991; 35: 579-581.
7. Fleiss JL. Statistical Methods for rates and proportions. 2nd edn., John Wiley & Sons, New York, 1981.
8. Shetty VP, Wakade AV, Antia NH et al. Clinical, histopathological and bacteriological investigations in two cases of relapse following ROM treatment. Lepr Rev, 2001; 72: 83-87.
9. Shukla P, Miranda MSM, Prabhudesai R, Rege VL. Single dose ROM therapy in Goa. Indian J Lepr, 2002; 74: 169-172.
10. Alam K, Butlin CR, Pahan D, Chowdhury SK. Long term follow-up of ROM treated cases. Lepr Rev, 2007; 78: 160.
11. World Health Organization. WHO Tech Advisory Group on Leprosy Control, Report, (Section 6. Clinical trials for treatment for paucibacillary leprosy with single dose of rifampicin, ofloxacin and minocycline: final Report). 1994.
12. Franzblau SG, Hastings RC. In vitro and in vivo activities of macrolides against M. Leprae. Antimicrob Agents Chemother, 1988; 32: 1758-1762.
13. Gelber RH, Siu P, Tsang M et al. Activities of various macrolide antibiotics against M. leprae infection in mice. Antimicrob Agents Chemother, 1991; 35: 760-763.
14. Derouin F, Caroff B, Chau F et al. Synergestic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrom Agents Chemother, 1992; 36: 252-255.
15. Revenkar CR, Pai VV, Bulchani HO, Ganapati R. Delayed clinical problems in single lesion PB leprosy after single dose ROM treatment (Abstract). Int J Lepr, 1998; 66: 16A.